New developments and challenges in therapy of aggressive B cell non-Hodgkin’s lymphoma

John P. Leonard, M.D., is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Associate Dean for Clinical Research at the Weill Cornell Medical College. He is Vice Chairman of the Weill Department of Medicine and Associate Director of the Meyer Cancer Center at Weill Cornell Medical College and New York Presbyterian Hospital, where he also serves as attending Physician and Director of the Joint Clinical Trials Office.

An expert in hematology and oncology, Dr. Leonard’s research has been published in numerous medical journals, and he has served as a member of the editorial boards of Blood and the Journal of Clinical Oncology, leading international journals in these fields. He is Chair of the Lymphoma Committee of the Alliance for Clinical Trials in Oncology (formerly CALGB, ACOSOG and NCCTG), a multicenter cooperative group and key component of the National Cancer Institute’s National Clinical Trials Network. Dr. Leonard has been an elected member of the American Board of Internal Medicine subspecialty board for Hematology, and he has also been elected to membership in the American Society of Clinical Investigation. He has served as chair of the Scientific Advisory Board and Board Member of the Lymphoma Research Foundation and Board Member of the Leukemia and Lymphoma Society/New York City Chapter.

Dr. Leonard’s primary research interest is in the development of novel therapeutic strategies for the treatment of lymphoma and related hematologic malignancies, and he has lectured at major international meetings on these topics. Much of his work has involved the development of novel therapies for lymphoma, including monoclonal antibodies, other immune-based treatments, targeted agents and other innovative approaches. He also has studied prognostic, imaging and survivorship issues for lymphoma patients. Dr. Leonard performed his undergraduate work at Johns Hopkins University and received his medical degree at the University of Virginia School of Medicine in Charlottesville, VA. He completed his residency in medicine at the New York Hospital-Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York, NY. He completed a fellowship in hematology and oncology at Cornell, and served as the chief medical at the New York Hospital-Cornell Medical Center.

时间、地点：2018年7月3日苏大附一院血液科（56区）三楼会议室下午14:00

报告名称：New developments and challenges in therapy of aggressive B cell non-Hodgkin’s lymphoma